The following information was provided by Noridian’s Medicare Part A Provider Outreach and Education Department. For questions or clarification on the information posted here, please contact Noridian.
1. Redeterminations Submitted in Noridian Medicare Portal:
Providers are encouraged to submit their redetermination requests and associated documentation through our portal. This prevents the requests from being dismissed for missing the signature and bypasses the time for carrier delivery. When the redetermination is finalized, the paid/favorable adjustments are included in remittance advices. The partially/fully unfavorable decision letters are available in the portal’s appeal status feature. If a redetermination is submitted in the portal, the decision letters are not mailed; providers can access them right away through the portal. Learn More!
2. New Electronic Funds Transfer (EFT) Form:
Form CMS-588 (01/17) found at https://www.cms.gov/Medicare/CMS-Forms/CMS-Forms/Downloads/CMS588.pdf. CMS requires all Medicare Part A providers that are enrolling, revalidating, or when the Employer Identification Number (EIN), Pay-to address or Legal Business Name (LBN) to their file is being changed, to complete the new EFT form. Review additional information and comments at:
3. New Advance Beneficiary Notice of Noncoverage (ABN) Form:
Form CMS-R-131 (Exp. 03/2020) available at https://www.cms.gov/Medicare/Medicare-General-Information/BNI/ABN.html. Effective June 21, 2017, providers must use the most recent version of the ABN form. After this date, any new ABN executed on the old form will be considered invalid and would result in provider liability if Medicare denies the claim. Learn More!
4. Recovery Audit Contractor (RAC) Activities:
HMS Federal Solutions has launched the new Region 4 Recovery Audit website located at https://racinfo.hms.com/home.aspx. Noridian encourages providers to review the New Issues section of the website in detail. Providers may use this information to prepare for potential requests for information if selected as part of any of the new issue reviews.